OrthoPediatrics Projects Strong 2026 Growth, Adjusted EBITDA Doubling, and Free Cash Flow Breakeven
KIDS sits 17% above its 52-week low of $15.28.
Summary
OrthoPediatrics Corp. filed an investor presentation detailing its full year 2025 financial results and providing strong 2026 guidance, including projected revenue growth, a near-doubling of Adjusted EBITDA, and Free Cash Flow breakeven.
Key Events · Earnings and Guidance · KIDS
-
Reports Full Year 2025 Financial Results
The company reported $236.3 million in total revenue for full year 2025, representing 15% growth over 2024, with a net loss of ($39.6 million) and diluted EPS of ($1.69).
-
Issues Strong 2026 Financial Guidance
OrthoPediatrics projects 2026 revenue between $262.0 million and $266.0 million (11% to 13% growth), Adjusted EBITDA of approximately $25.0 million (nearly double 2025's $14.8 million), and anticipates achieving Free Cash Flow breakeven.
-
Highlights Strategic Growth Initiatives
The investor presentation details ongoing aggressive R&D, strategic acquisitions like Boston Orthotics & Prosthetics, and expansion of its Specialty Bracing (OPSB) division with plans for 18 new markets by 2027.
-
Provides Comprehensive Business Overview
The filing includes a detailed investor presentation outlining the company's market opportunity, broad product portfolio, commercial execution, and commitment to clinical education in pediatric orthopedics.
Analysis · KIDS · Industrial Applications And Services
This 8-K filing, accompanied by a comprehensive investor presentation, provides a detailed update on OrthoPediatrics' strategic direction and financial outlook. The most significant takeaway is the robust 2026 guidance, which projects substantial growth in Adjusted EBITDA and a move towards Free Cash Flow breakeven. This signals a positive shift towards profitability and improved financial health for the growth-oriented company. The detailed presentation also reinforces the company's strong market position in pediatric orthopedics, aggressive R&D, and strategic expansion plans, which are crucial for long-term value creation.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KIDS was trading at $17.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $446.1M. The 52-week trading range was $15.28 to $26.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.